This announcement is a separate document:
安永华明会计师事务所（特殊普通合伙）关于诺诚健华医药有限公司2023年度营业收入扣除情况专项说明
Ernst & Young Huaming Certified Public Accountants (Special General Partnership) Special Notice on the 2023 Operating Income Deduction Situation of Nuochengjianhua Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.